Skip to main content

Advertisement

Log in

Tumor burden evaluation in NF1 patients with plexiform neurofibromas in daily clinical practice

  • Clinical Article - Pediatrics
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

An Erratum to this article was published on 12 April 2015

Abstract

Background

Existing volumetric measurements of plexiform neurofibromas (PNs) are time consuming and error prone, as they require delineation of PN boundaries, a procedure that is not practical in the typical clinical setting. The aim of this study is to assess the Plexiform Neurofibroma Instant Segmentation Tool (PNist), a novel semi-automated segmentation program that we developed for PN delineation in a clinical context. PNist was designed to greatly simplify volumetric assessment of PNs through use of an intuitive user interface while providing objectively consistent results with minimal interobserver and intraobserver variabilities in reasonable time.

Materials and methods

PNs were measured in 30 magnetic resonance imaging (MRI) scans from 12 patients with neurofibromatosis 1. Volumetric measurements were performed using PNist and compared to a standard semi-automated volumetric method (Analyze 9.0).

Results

High correlation was detected between PNist and the semi-automated method (R 2 = 0.996), with a mean volume overlap error of 9.54 % and low intraobserver and interobserver variabilities. The segmentation time required for PNist was 60 % of the time required for Analyze 9.0 (360 versus 900 s, respectively). PNist was also reliable when assessing changes in tumor size over time, compared to the existing commercial method.

Conclusions

Our study suggests that the new PNist method is accurate, intuitive, and less time consuming for PN segmentation compared to existing commercial volumetric methods. The workflow is simple and user-friendly, making it an important clinical tool to be used by radiologists, neurologists and neurosurgeons on a daily basis, helping them deal with the complex task of evaluating PN burden and progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mautner VF, Hartmann M, Kluwe L, Friedrich RE, Funsterer C (2006) MRI growth patterns of plexiform neurofibromas in patient with neurofibromatosis type 1. Neuroradiology 48:160–165

    Article  CAS  PubMed  Google Scholar 

  2. Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL (2009) Neurofibromatosis type 1 revisited. Pediatrics 123:124–133

    Article  PubMed  Google Scholar 

  3. Tucker T, Friedman JM, Friedrich RW, Funsterer C, Mautner VF (2009) Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas. J Med Genet 46(2):81–85

    Article  CAS  PubMed  Google Scholar 

  4. Solomon J, Warren K, Dombi E, Patronas N, Widemann B (2004) Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging. Comput Med Imaging Graph 28(5):257–265

    Article  PubMed  Google Scholar 

  5. Poussaint TY, Jaramillo D, Chang Y, Korf B (2003) Interobserver reproducibility of volumetric MR imaging measurements of plexiform neurofibromas. AJR Am J Roentgenol 180(2):419–423

    Article  PubMed  Google Scholar 

  6. Nguyen R, Kluwe L, Fuensterer C, Kentsch M, Friedrich RE, Mautner VF (2011) Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits. J Pediatr 159(4):652–655

    Article  PubMed  Google Scholar 

  7. Nguyen R, Dombi E, Widemann BC, Solomon J, Fuensterer C, Kluwe L, Friedman JM, Mautner VF (2012) Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1. Orphanet J Rare Dis 7:75

    Article  PubMed Central  PubMed  Google Scholar 

  8. Ros PR, Eshaghi N (1991) Plexiform neurofibroma of the pelvis: CT and MRI findings. Magn Reson Imaging 9:463–465

    Article  CAS  PubMed  Google Scholar 

  9. Stull MA, Moser RP, Kransdorf MJ, Bogumill GP, Nelson MC (1991) Magnetic resonance appearance of peripheral nerve sheath tumors. Skelet Radiol 20(1):9–14

    Article  CAS  Google Scholar 

  10. Tien RD, Hesselink JR, Chu PK, Szumowski J (1991) Improved detection and delineation of head and neck lesions with fat suppression spin-echo MR imaging. AJNR Am J Neuroradiol 12:19–24

    CAS  PubMed  Google Scholar 

  11. Cai W, Kassarjian A, Bredella MA, Harris GJ, Yoshida H, Mautner VF, Wenzel R, Plotkin SR (2009) Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images. Radiology 250:665–673

    Article  PubMed  Google Scholar 

  12. Weizman L, Hoch L, Ben-Bashat D, Joskowicz L, Pratt LT, Constantini S, Ben Sira L (2012) Interactive segmentation of plexiform neurofibroma tissue: method and preliminary performance evaluation. Med Biol Eng Comput 50(8):877–884

    Article  PubMed  Google Scholar 

  13. Weizman L, Helfer D, Ben Bashat D, Pratt LT, Joskowicz L, Constantini S, Shofty B, Ben Sira L (2014) PNist: interactive volumetric measurements of plexiform neurofibromas in MRI scans. Int J Comput Assist Radiol Surg 9(4):683–693

    Article  PubMed  Google Scholar 

  14. Dombi E, Solomon J, Gillespie AJ, Fox E, Balis FM, Patronas ER, Korf BR, Babovic-Vuksanovic D, Packer RG, Belasco J, Goldman S, Jakacki R, Kieran M, Steinberg M, Weidemann BC (2007) NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology 68:643–647

    Article  CAS  PubMed  Google Scholar 

  15. Mautner VF, Asuagbor FA, Dombi E, Funsterer C, Kluwe L, Wenzel R, Widemann BC, Friedman JM (2008) Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol 10:593–598

    Article  PubMed Central  PubMed  Google Scholar 

  16. Van Meerbeeck SFL, Verstraete KL, Janssens S, Mortier G (2009) Whole body MR imaging in neurofibromatosis type 1. Eur J Radiol 69:236–242

    Article  PubMed  Google Scholar 

  17. Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, Merker VL, Munn LL, Muzikansky A, Askenazi M, Nguyen R, Wenzel R, Mautner VF (2012) Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS ONE 7(4):e35711

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None of the authors has any conflict of interest and/or commercial stake in the evaluated software.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Pratt.

Additional information

Presentation at a conference:

L. Pratt, D. Helfer, L. Weizman, B. Shofty, S. Constantini, L. Joskowicz, D. Ben Bashat, L. Ben-Sira. "PNist”: a novel semi-automated volumetric method for easy segmentation of plexiform neurofibromas—a practical tool for the clinicians. Poster presentation at EANS 2013, 11–14 November 2013, Tel-Aviv, Israel

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pratt, L., Helfer, D., Weizman, L. et al. Tumor burden evaluation in NF1 patients with plexiform neurofibromas in daily clinical practice. Acta Neurochir 157, 855–861 (2015). https://doi.org/10.1007/s00701-015-2366-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-015-2366-z

Keywords

Navigation